US8658219B2ActiveUtilityA1

Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin

97
Assignee: PIERGALLINI REMIGIOPriority: Nov 7, 2008Filed: Nov 6, 2009Granted: Feb 25, 2014
Est. expiryNov 7, 2028(~2.3 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 17/10A61P 17/02A61P 17/00A61P 1/02A61K 31/353A61N 5/0616A61K 47/46A61K 47/22A61K 47/26A61K 9/06A61K 45/06A61K 33/40A61K 31/7008A61Q 19/08A61K 8/37A61K 8/4946A61K 31/4166A61K 31/728A61Q 19/00A61K 31/403A61K 47/38A61K 8/60A61K 41/0057A61K 8/736A61K 8/22A61K 8/735A61N 2005/0663A61K 31/404A61N 5/062A61K 8/492A61K 31/17A61Q 1/145A61K 8/498A61K 8/732A61K 8/42A61K 31/737A61K 47/36A61K 8/042A61N 2005/0662A61K 47/02A61K 47/183
97
PatentIndex Score
32
Cited by
128
References
9
Claims

Abstract

There is provided a skin rejuvenation composition which comprises at least one oxidant, at least one photoactivator capable of activating the oxidant, and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin, in association with a pharmaceutically acceptable carrier.

Claims

exact text as granted — not AI-modified
The invention claimed is: 
     
       1. A method for reversing or mitigating skin aging, comprising:
 a) topically applying on a patient's skin a composition comprising at least one oxidant, at least one photoactivator that is a fluorescent dye capable of activating the oxidant and at least one healing factor selected from hyaluronic acid, glucosamine and allantoin; and 
 b) exposing said composition to actinic light having an emission wavelength between about 400 nm and about 600 nm for a time sufficient to activate said oxidant; 
 wherein the method reverses or mitigates skin aging. 
 
     
     
       2. The method according to  claim 1 , wherein the oxidant is selected from hydrogen peroxide, carbamide peroxide and benzoyl peroxide. 
     
     
       3. The method according to  claim 1 , which further comprises at least one hydrophilic gelling agent. 
     
     
       4. The method according to  claim 1 , which further comprises at least one chelating agent selected from ethylenediaminetetraacetic acid (EDTA) and ethylene glycol tetraacetic acid (EGTA). 
     
     
       5. The method according to  claim 1 , which further comprises at least one lipolysis stimulating factor selected from caffeine and paraxanthine. 
     
     
       6. The method according to  claim 1 , wherein the at least one photoactivator is eosin Y. 
     
     
       7. The method according to  claim 1 , wherein the at least one photoactivator is selected from a xanthene derivative dye, an azo dye, a biological stain and a carotenoid. 
     
     
       8. The method according to  claim 6 , wherein the composition comprises at least one additional photoactivator selected from phloxine B, rose bengal, eosin B, fluorescein, erythrosine B, rhodamine B, rhodamine G, rhodamine WT, saffron red powder, annatto extract, brown algae extract, saffranin O, basic fuchsin, acid fuschin, 3,3′ dihexylocarbocyanine iodide, carminic acid, indocyanine green, crocetin, α-crocin (8,8-diapo-8,8-carotenoic acid), merbromine, zeaxanthine, lycopene, α-carotene, β-carotene, bixin, fucoxanthine, methyl violet, neutral red, para red, amaranth, carmoisine, allura red AC, tartrazine, orange G, ponceau 4R, methyl red, murexide-ammonium purpurate, pyronine Y and pyronine B. 
     
     
       9. The method according to  claim 1 , wherein the composition is exposed to the actinic light for about 60 seconds to 5 minutes, or about 60 seconds to 5 minutes per cm 2  of treatment area.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.